0.72

1.11% 0.0079

After Hours: .74 0.02 +2.78%

InspireMD Inc. (NSPR)

Overview News Price History Option Chain Discussions Forecast Stock Split

InspireMD Inc. stock is traded at $0.72, with a volume of 159.08K. It is up +1.11% in the last 24 hours and down -7.14% over the past month. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Previous Close:

$0.7121

Open:

$0.72

24h Volume:

159.08K

Relative Volume:

0.58

Market Cap:

$33.72M

Revenue:

$10.85M

Net Income/Loss:

$-51.31M

P/E Ratio:

-0.9769

EPS:

-0.737

Net Cash Flow:

$-40.15M

1W Performance:

+3.00%

1M Performance:

-7.14%

6M Performance:

-58.14%

1Y Performance:

-70.37%

1-Day Range:

$0.6701

$0.72

1-Week Range:

$0.6601

$0.72

52-Week Range:

$0.63

$2.9319

InspireMD Inc. Stock (NSPR) Company Profile

Name

InspireMD Inc.

Sector

Healthcare (1096)

Industry

Medical Devices (140)

Phone

972 3 6917691

Address

4 Menorat Hamaor Street, Tel Aviv

Employee

Twitter

@InspireMD

Next Earnings Date

2026-08-03

Latest SEC Filings

NSPR's Discussions on Twitter

Compare NSPR vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NSPR InspireMD Inc.	0.72	33.72M	10.85M	-51.31M	-40.15M	-0.737
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

InspireMD Inc. Stock (NSPR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-02-26	Initiated	Maxim Group	Buy
Jan-07-16	Initiated	Rodman & Renshaw	Buy
Mar-13-15	Downgrade	Oppenheimer	Outperform → Perform
Nov-26-13	Initiated	Oppenheimer	Outperform

InspireMD Inc. Stock (NSPR) Latest News

Jul 02, 2026

InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026 - TradingView

Jul 02, 2026

Board member Raymond Cohen to leave InspireMD (NSPR) effective July 1, 2026 - Stock Titan

Jul 02, 2026

Jun 29, 2026

Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $4 - Moomoo

Jun 29, 2026

InspireMD, Inc.(NasdaqCM: NSPR) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits

Jun 28, 2026

InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Price to sales forward of InspireMD Inc. – NASDAQ:NSPR - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBITDA forward of InspireMD Inc. – NASDAQ:NSPR - TradingView

Jun 25, 2026

Enterprise value to revenue forward of InspireMD Inc. – NASDAQ:NSPR - TradingView

Jun 25, 2026